![4-(2-[2-甲氧基-4-(4,4,5,5-四甲基-[1,3,2]二噁硼烷-2-基)-苯氧基]-乙基)-吗啉结构式](https://www.chemsrc.com/caspic/348/864754-10-9.png)
4-(2-[2-甲氧基-4-(4,4,5,5-四甲基-[1,3,2]二噁硼烷-2-基)-苯氧基]-乙基)-吗啉结构式
|
常用名 | 4-(2-[2-甲氧基-4-(4,4,5,5-四甲基-[1,3,2]二噁硼烷-2-基)-苯氧基]-乙基)-吗啉 | 英文名 | 4-(2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-MORPHOLINE |
|---|---|---|---|---|
| CAS号 | 864754-10-9 | 分子量 | 363.25600 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C19H30BNO5 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | 4-(2-[2-甲氧基-4-(4,4,5,5-四甲基-[1,3,2]二噁硼烷-2-基)-苯氧基]-乙基)-吗啉 |
|---|---|
| 英文名 | 4-[2-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]morpholine |
| 英文别名 | 更多 |
| 分子式 | C19H30BNO5 |
|---|---|
| 分子量 | 363.25600 |
| 精确质量 | 363.22200 |
| PSA | 49.39000 |
| LogP | 1.64330 |
|
~%
4-(2-[2-甲氧基-4-(... 864754-10-9 |
| 文献：HUTCHISON MEDIPHARMA LIMITED; Su, Wei-Guo; Deng, Wei; Ji, Jianguo Patent: US2014/121200 A1, 2014 ; Location in patent: Paragraph 0176; 0179; 0180 ; |
| 4-{2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL}-MORPHOLINE |
| Morpholine,4-[2-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl] |
